Company intelligence / Profile preview

Gyder Surgical

Mulgrave, Victoria, Australia

Ownership: Private
Employees: ~25
Development stage: Other

Overview

The GYDER Hip System has received FDA 510(k) clearance in the US and TGA approval in Australia as the first commercially available pin-less and image-less navigation solution for accurate acetabular cup placement during anterior hip arthroplasty. It has been used in successful surgeries in Australia and India. Clinical significance relates to reducing post-surgery complications by improving cup placement accuracy.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Gyder Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gyder Surgical.

Explore the full profile